State Board of Administration of Florida Retirement System’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,377
Closed -$1.28M 2416
2018
Q2
$1.28M Buy
9,377
+720
+8% +$65.4K ﹤0.01% 1338
2018
Q1
$682K Buy
8,657
+147
+2% +$10.8K ﹤0.01% 1650
2017
Q4
$580K Buy
8,510
+170
+2% +$8.82K ﹤0.01% 1774
2017
Q3
$335K Hold
8,340
﹤0.01% 2066
2017
Q2
$332K Buy
8,340
+1,585
+23% +$58K ﹤0.01% 2076
2017
Q1
$218K Buy
+6,755
New +$169K ﹤0.01% 2182
2015
Q2
Sell
-13,731
Closed -$661K 2471
2015
Q1
$661K Buy
13,731
+2,426
+21% +$110K ﹤0.01% 1795
2014
Q4
$251K Hold
11,305
﹤0.01% 2294
2014
Q3
$214K Hold
11,305
﹤0.01% 2346
2014
Q2
$305K Buy
+11,305
New +$287K ﹤0.01% 2272

State Board of Administration of Florida Retirement System's FMI Position: Q3 2018 in Review

State Board of Administration of Florida Retirement System sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 9,377 shares — an estimated $1.28M sold.

State Board of Administration of Florida Retirement System first reported a position in FMI in Q2 2014 and held it in 10 quarters. The position peaked at $1.28M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • State Board of Administration of Florida Retirement System reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 9,377 Foundation Medicine, Inc. shares in Q3 2018, an estimated $1.28M.
  • State Board of Administration of Florida Retirement System first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 10 quarters.
  • State Board of Administration of Florida Retirement System's Foundation Medicine, Inc. position peaked at $1.28M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2018, filed 31 Oct 2018.